Find out about our capabilities in different geographies

Background

Whilst pressure on healthcare budgets clearly exists, demand for in vitro diagnostic testing appears to be increasing as countries recognise its utility in the early detection and treatment of disease.

This market is, nonetheless, diverse and can be segmented according to:

  • Product Type / Technology (i.e. clinical chemistry, immunochemistry, haematology, histology / cytology, infection immunology, microbiology and genetic testing)
  • Application (e.g. for diabetes, cancer, cardiovascular and infectious diseases)
  • Location (i.e. laboratory versus point of care testing)

For Molecular Diagnostics, please also see Personalized Medicine

Globe provides specialist commercial evaluation and information to support strategic decision making for companies operating in this field (see Our Services).